
Danish biotech 21st.Bio has filed an EU Novel Food application for precision-fermented bovine beta-lactoglobulin, the main protein in whey. The protein is made without animals and received US regulatory approval in October 2025.
The company is calling for a fast-track EU pathway for nature-identical proteins.
If approved, animal-free BLG could add supply to a whey protein market already constrained, though approval would take time. The filing is a long-term potential substitute rather than an immediate change in whey supply.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.